Related Experiment Video

Updated: May 24, 2026

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
10:49

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus

Published on: January 28, 2019

Potential impact of accelerating the primary dose of rotavirus vaccine in infants

Elizabeth E Halvorson1, Timothy R Peters, Beverly M Snively

  • 1Department of Pediatrics, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, USA.

Vaccine
|March 1, 2012
PubMed

Insights

Administering the rotavirus vaccine at 6 weeks instead of 8 weeks could prevent thousands of infant hospitalizations. This early vaccination strategy offers a significant reduction in rotavirus cases for young children.

Area of Science:

  • Pediatrics
  • Vaccinology
  • Public Health

Background:

  • Rotavirus is a leading cause of severe gastroenteritis in infants.
  • Current U.S. recommendations allow rotavirus vaccine administration starting at 2 months of age.
  • Earlier vaccination may enhance protection against rotavirus disease.

Purpose of the Study:

  • To estimate the impact of administering the first rotavirus vaccine dose at 6 weeks versus 2 months of age.
  • To determine the potential reduction in rotavirus hospitalizations among infants.

Main Methods:

  • Utilized published data on rotavirus hospitalization rates, vaccine coverage, and single-dose efficacy.
  • Modeled the effect of a 6-week first dose, accounting for a 2-week seroconversion delay.
  • Calculated potential hospitalizations prevented in infants under 3 months and children under 5 years.

Main Results:

  • Administering the first rotavirus vaccine dose at 6 weeks could have prevented 1110, 1660, and 2210 hospitalizations in U.S. infants under 3 months in 2006.
  • This represents a 2-4% reduction in overall rotavirus hospitalizations for children under 5 years.

Conclusions:

  • An earlier first dose of rotavirus vaccine (at 6 weeks) is a viable strategy to reduce infant hospitalizations.
  • Optimizing vaccine schedules can enhance public health outcomes and decrease healthcare burden.

More Related Videos

Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins11:40

Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins

Published on: April 17, 2020

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay09:14

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay

Published on: January 26, 2019

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Vaccinations01:51

Vaccinations

Overview